NRXP
NASDAQ · Pharmaceuticals
Nrx Pharmaceuticals Inc
$3.32
-0.07 (-2.06%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+541.0% upside
Low Target
$14.65
Average Target
$21.28
High Target
$27.46
Current Price
$3.32
Current
$3.32
$3.32
Target
$21.28
$21.28
$14.65
$21.28 avg
$27.46
Scenario Analysis
Bear Case
$14.65
341.3%
Low target
Base Case
$21.28
+541.0%
Avg target
Bull Case
$27.46
+727.1%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$5.06
-34.3% from high
52-Week Low
$1.62
+104.9% from low
Target vs 52W High
$21.28
+321.0% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +13.7% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.3% |
| MRK | Buy | 36 | 72% | $159.27 | +5.5% |
| PFE | Hold | 36 | 39% | $33.90 | +21.4% |
| BMY | Hold | 35 | 43% | $174.50 | +180.3% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +188.0% |